Deciphering complicated pharmacology with cardiovascular toxicity assays

Clyde has performed a number of mechanistic cardio vascular toxicity studies for pharma companies to decipher complicated pharmacology discovered during the in vivo testing.

Typically, a comprehensive analysis of cardiomyocyte function using our chronic cardiotoxicity model and chronic cardiomyocyte assay can highlight the following mechanisms of toxicity;

  • Acute versus chronic effects

  • hERG trafficking

  • Chronotropic liability

  • Left ventricle dysfunction (negative inotropy)

  • Proarrhythmic risk

  • Mixed ion channel effects over time

  • Cytotoxicity (structural) though change in myocyte function

 

Typical Data – Pentamidine

Typical data from a Clyde Mechanistic Cardiovascular Toxicity Assay – Pentamidine
 

Start a study with Clyde


To enquire about how Clyde could help with your project complete the enquiry form below and we’ll be get back to you as soon as we can. Alternatively email us at info@clydebio.com